Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GLRA3 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
mRNA | NLRP4 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
mRNA | APBA3 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
mRNA | TYROBP | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
mRNA | RBM22 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
mRNA | C2orf83 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
mRNA | ABHD15 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
mRNA | PKN1 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
mRNA | TTC37 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
mRNA | R3HDML | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |